« Back
Home /
Anti-Human TACI - 0.1 mg

Anti-Human TACI - 0.1 mg

Item no.	LEIN-T305-0.1mg
Manufacturer	Leinco Technologies
Amount	0.1 mg
Quantity options	0.1 mg 20 ug
Category	Antibodies Immunohistochemistry Western Blot Primary Antibodies
Type	Antibody Primary
Applications	WB, IHC
Specific against	Human (Homo sapiens)
Host	Rabbit
Citations	1. Schwaller, J. et al. (2007) Blood 109: 331 2. Slazer, U. et al. (2005) Nat Genet. 37: 820 3. Bonilla, FA. et al. (2006) Curr Allergy Asthma Rep. 6: 357 4. Bram, RJ. et al. (2000) Mamm Genome. 11: 628 5. Kobata, T. et al. (2007) Blood 109: 2961
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Shipping Condition	Room temperature
Available
Manufacturer - Applications	IHC FFPE, WB
Manufacturer - Category	Primary Monoclonal Antibodies>Apoptosis & Cell Biology
Manufacturer - Targets	TACI
Country of Origin	USA
Shipping Temperature	Next Day Ambient
Storage Conditions	This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Product Description	Transmembrane activator & calcium modulator and cyclophilin ligand (CAML) interactor (TACI) is lymphocyte specific member1, 2 of the tumor necrosis factor-receptor superfamily3 and is expressed in B-lymphocytes and may act to regulate humoral immunity.4 TACI also serves as a receptor for B-cell activating factor of the TNF family (BAFF) and as a proliferation-inducing ligand (APRIL).5
Background	Transmembrane activator & calcium modulator and cyclophilin ligand (CAML) interactor (TACI) is lymphocyte specific member^{1, 2} of the tumor necrosis factor-receptor superfamily³ and is expressed in B-lymphocytes and may act to regulate humoral immunity.⁴ TACI also serves as a receptor for B-cell activating factor of the TNF family (BAFF) and as a proliferation-inducing ligand (APRIL).⁵
PubMed	TACI
Manufacturer - Specificity	Rabbit Anti-Human TACI recognizes Human TACI. This polyclonal antibody was purified using affinity chromatography.
RRID	AB_2831893
Concentration	0.5 mg/ml
Formulation	This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Immunogen	PN:T325
Additional Information	Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Keywords	Polyclonal Antibody, Transmembrane Activator & Calcium Modulator and Cyclophilin Ligand, TNFRSF13B, CD267, CVID, FLJ39942, MGC133214, MGC39952, TNFRSF14B, TACI, Human, Anti-Human TACI, TACI Antibody, CVID, RYZN, TACI, CD267, CVID2, TNFRSF14B, Tumor necrosis factor receptor superfamily member 13B, Transmembrane activator and CAML interactor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

LEIN-T305-0.1mg-safety-datasheet.pdf